Write You
#1 in Business Subscribe Email Print

You are here: Home > News and Society > Politics > Should There be Limits on Contributions to Political Campaigns by Individuals?

Tags

  • combinations
  • against
  • usfda
  • developing combination
  • developing combination
  • companies involved

  • Links

  • America's Top Ten Unisex Baby Names
  • When Managers Become Hamlets
  • Seven Reasons Why Goals Matter
  • Write You - Should There be Limits on Contributions to Political Campaigns by Individuals?

    Yes there should be, every time. However, it shouldn't be in the actual amount of money bei
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ng pledged, but in the percentage being contributed.

    The main reason why any limits must b
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    e mandatory is because there is no such thing as a FREE lunch. No one gives politicians any
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    thing for free because, behind every donation, no matter how small, is the hope of some rew
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ard. The man in the street who might donate $1 is hoping that the politician will act in hi
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    favour when it comes to laws and initiatives which will affect him and his family, like re
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    duced taxes etc. Just as the millionaire with his thousands is hoping that his business, or
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ganisation, product or service, will be catered for in legislation or protected against any
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    adverse lawmaking.

    So no one gives politically for the sake of it. That is why politician
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    s have to be protected from being obliged to businesses and interest groups who could use t
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    e power of their money to get what they want, which might be against the public interest, a
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    nd put undue pressure on them. That is what is happening in the UK at the moment in the cas
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    h for peerages scandal where big businessmen have repeatedly donated to the government in p
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ower with the unwritten expectation of either getting a peerage, a knighthood or having pre
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ferential treatment for their businesses when it comes to the law or other aspects of gover
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ment. This is not good to establish fair government for all.

    Limiting the amount people co
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ntribute to elections keeps a fairer playing field between contributors. Moreover, by limit
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ing the donation by percentage rather than actual amount, it means that people with money a
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    lso get the opportunity to donate according to their capacity, because 1% of a $1000 income
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    is far less than 1% of $1 billion. This varied amount should keep everyone happy all round


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.writeyou.org.ua/article/191634/writeyou-Should-There-be-Limits-on-Contributions-to-Political-Campaigns-by-Individuals.html">Should There be Limits on Contributions to Political Campaigns by Individuals?</a>

    BB link (for phorums):
    [url=http://www.writeyou.org.ua/article/191634/writeyou-Should-There-be-Limits-on-Contributions-to-Political-Campaigns-by-Individuals.html]Should There be Limits on Contributions to Political Campaigns by Individuals?[/url]

    Related Articles:

    How To Make Your Blog Appealing

    Five Benefits of Email Marketing

    Applying for a Phoenix Mortgage

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com